ClinicalTrials.govpublic full text
Salivary C1P and PGE2 Levels in Periodontitis Patients With T2DM and Effect of Non-Surgical Periodontal Treatment
periodontitis, type 2 diabetes, saliva, prostaglandin e2, ceramide-1-phosphate, non-surgical periodontal treatment, phase i periodontal therapy, saliva biomarker, metabolic control, hba1c, pge2, c1p
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 917933
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.